A Clinical Study to Evaluate Bone Healing and Stability of Dental Implants With and Without Bone Regenerative Liquid.

Evaluation of the Effect of Bone Bioactive Liquid on Osseointegration A Randomised Control Trial Assessing Primary stability and Bone Turnover Markers - Nil

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/04/107747

Enrollment

Registered

2026-04-07

Start date

Unknown

Completion date

Unknown

Last updated

2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Bone Bioactive Liquid ( Theravex): Bioactive Liquid (BBL) is a promising biostimulatory agent that may accelerate bone healing by modulating bone metabolism and enhancing implant stabil

Eligibility

Inclusion criteria

Inclusion criteria: Patients who are willing to replace the missing teeth with implants in single or multiple edentulous sites with Adequate bone height of 10mm and bone width of 6mm No systemic illness

Exclusion criteria

Exclusion criteria: Uncontrolled diabetics mellitus History of bone metabolic disorders History of smoking more than 10 cigarettes per day Inadequate bone volume Presence of untreated periapical kesions , cysts and tumours pregnancy and lactating mothers

Design outcomes

Primary

Measure	Time frame
The study is expected to demonstrate that the application of Bone Bioactive Liquid (BBL) at the implant site enhances osseointegration by improving implant stability and bone turnover activity compared to conventional implant placement.Timepoint: Baseline , 1 month and 3 months post implantation	—

Secondary

Measure	Time frame
Bone Turn over Markers Timepoint: Baseline , 1 month and 3 months post implantation	—

Countries

India

Contacts

Public ContactDr A R Sowmya Ranjana

Sri Ramachandra Dental College and Hospitals

d0323001@sriher.edu.in9353451968

Outcome results